These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 21846440)

  • 21. Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?
    Hsieh CH; ChangChien CC; Lin H; Huang EY; Huang CC; Lan KC; Chang SY
    Gynecol Oncol; 2002 Jul; 86(1):28-33. PubMed ID: 12079296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node metastasis in endometrioid adenocarcinomas of the uterine corpus with occult cervical involvement.
    Boren T; Lea J; Kehoe S; Miller DS; Richardson D
    Gynecol Oncol; 2012 Oct; 127(1):43-6. PubMed ID: 22713294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphovascular space invasion and cervical stromal invasion are independent risk factors for nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli M; Turan V; Gungorduk K; Hasdemir P; Tosun G; Dogan A; Ozdemir A; Adiyeke M; Sanci M
    Aust N Z J Obstet Gynaecol; 2015 Feb; 55(1):81-6. PubMed ID: 25688821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian preservation in young women with endometrial cancer of endometrioid histology.
    Kinjyo Y; Kudaka W; Ooyama T; Inamine M; Nagai Y; Aoki Y
    Acta Obstet Gynecol Scand; 2015 Apr; 94(4):430-4. PubMed ID: 25603833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The novel criteria for predicting pelvic lymph node metastasis in endometrioid adenocarcinoma of endometrium.
    Akbayir O; Corbacioglu A; Goksedef BP; Numanoglu C; Akca A; Guraslan H; Bakir LV; Cetin A
    Gynecol Oncol; 2012 May; 125(2):400-3. PubMed ID: 22310644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma.
    Modarres-Gilani M; Vaezi M; Shariat M; Zamani N; Nourizadeh R
    Cancer Biomark; 2017 Aug; 20(2):135-141. PubMed ID: 28800309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preoperative serum CA125: a useful marker for surgical management of endometrial cancer.
    Jiang T; Huang L; Zhang S
    BMC Cancer; 2015 May; 15():396. PubMed ID: 25964114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.
    Yang B; Shan B; Xue X; Wang H; Shan W; Ning C; Zhou Q; Chen X; Luo X
    PLoS One; 2016; 11(5):e0155145. PubMed ID: 27163153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome.
    Sood AK; Buller RE; Burger RA; Dawson JD; Sorosky JI; Berman M
    Obstet Gynecol; 1997 Sep; 90(3):441-7. PubMed ID: 9277659
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical implications of positive peritoneal cytology in endometrial cancer].
    Ren YL; Wang HY; Shan BE; Ping B; Shi DR
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):595-9. PubMed ID: 22169518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative cervical cytology in endometrial carcinoma and its clinicopathologic relevance.
    Fukuda K; Mori M; Uchiyama M; Iwai K; Iwasaka T; Sugimori H; Yamasaki F
    Gynecol Oncol; 1999 Mar; 72(3):273-7. PubMed ID: 10053095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrasound-based risk model for preoperative prediction of lymph-node metastases in women with endometrial cancer: model-development study.
    Eriksson LSE; Epstein E; Testa AC; Fischerova D; Valentin L; Sladkevicius P; Franchi D; Frühauf F; Fruscio R; Haak LA; Opolskiene G; Mascilini F; Alcazar JL; Van Holsbeke C; Chiappa V; Bourne T; Lindqvist PG; Van Calster B; Timmerman D; Verbakel JY; Van den Bosch T; Wynants L
    Ultrasound Obstet Gynecol; 2020 Sep; 56(3):443-452. PubMed ID: 31840873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk-scoring system for the individualized prediction of lymphatic dissemination in patients with endometrioid endometrial cancer.
    AlHilli MM; Podratz KC; Dowdy SC; Bakkum-Gamez JN; Weaver AL; McGree ME; Keeney GL; Cliby WA; Mariani A
    Gynecol Oncol; 2013 Oct; 131(1):103-8. PubMed ID: 23845691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of tumor-free distance and depth of myometrial invasion as prognostic factors for lymph node metastases in endometrial cancer.
    Kondalsamy-Chennakesavan S; van Vugt S; Sanday K; Nicklin J; Land R; Perrin L; Crandon A; Obermair A
    Int J Gynecol Cancer; 2010 Oct; 20(7):1217-21. PubMed ID: 21495232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer.
    Yabushita H; Shimazu M; Yamada H; Sawaguchi K; Noguchi M; Nakanishi M; Kawai M
    Gynecol Oncol; 2001 Feb; 80(2):139-44. PubMed ID: 11161851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative Risk Stratification of Endometrial Carcinoma: L1CAM as a Biomarker.
    Pasanen A; Loukovaara M; Tuomi T; Bützow R
    Int J Gynecol Cancer; 2017 Sep; 27(7):1318-1324. PubMed ID: 29059097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study on cytokeratin and CA125 for diagnosing lymph node micrometastases in endometrial cancer].
    Liu FH; Wang YF; Wang J; Xue Q; Jiang S; Ma YY
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):612-5. PubMed ID: 15498190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual expression of immunoreactive estrogen receptor β and p53 is a potential predictor of regional lymph node metastasis and postoperative recurrence in endometrial endometrioid carcinoma.
    Obata T; Nakamura M; Mizumoto Y; Iizuka T; Ono M; Terakawa J; Daikoku T; Fujiwara H
    PLoS One; 2017; 12(11):e0188641. PubMed ID: 29190668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measurement of the minimum apparent diffusion coefficient (ADCmin) of the primary tumor and CA125 are predictive of disease recurrence for patients with endometrial cancer.
    Nakamura K; Imafuku N; Nishida T; Niwa I; Joja I; Hongo A; Kodama J; Hiramatsu Y
    Gynecol Oncol; 2012 Feb; 124(2):335-9. PubMed ID: 22008707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.